Stan Berenshteyn
Stock Analyst at Wells Fargo
(1.10)
# 3,815
Out of 5,127 analysts
78
Total ratings
34.04%
Success rate
-14.47%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stan Berenshteyn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DOCS Doximity | Maintains: Overweight | $55 → $45 | $27.24 | +65.20% | 14 | Feb 6, 2026 | |
| PHR Phreesia | Initiates: Overweight | $30 | $12.41 | +141.74% | 1 | Jan 9, 2026 | |
| HNGE Hinge Health | Initiates: Overweight | $68 | $33.05 | +105.75% | 1 | Jan 9, 2026 | |
| WAY Waystar Holding | Initiates: Overweight | $41 | $23.50 | +74.47% | 1 | Jan 9, 2026 | |
| CTEV Claritev | Initiates: Equal-Weight | $33 | $22.08 | +49.46% | 1 | Jan 9, 2026 | |
| OMDA Omada Health | Initiates: Equal-Weight | $17 | $11.33 | +50.04% | 1 | Jan 9, 2026 | |
| OMCL Omnicell | Maintains: Overweight | $43 → $52 | $39.00 | +33.33% | 18 | Jan 5, 2026 | |
| VEEV Veeva Systems | Maintains: Overweight | $341 → $333 | $186.99 | +78.08% | 9 | Nov 25, 2025 | |
| HCAT Health Catalyst | Maintains: Overweight | $6 → $5 | $2.05 | +143.90% | 7 | Nov 11, 2025 | |
| AMWL American Well | Maintains: Overweight | $12 → $9 | $4.41 | +104.08% | 5 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $10 → $8 | $4.85 | +64.95% | 3 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $8 → $7 | $2.33 | +200.43% | 8 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $125 | $78.35 | +59.54% | 9 | Feb 26, 2025 |
Doximity
Feb 6, 2026
Maintains: Overweight
Price Target: $55 → $45
Current: $27.24
Upside: +65.20%
Phreesia
Jan 9, 2026
Initiates: Overweight
Price Target: $30
Current: $12.41
Upside: +141.74%
Hinge Health
Jan 9, 2026
Initiates: Overweight
Price Target: $68
Current: $33.05
Upside: +105.75%
Waystar Holding
Jan 9, 2026
Initiates: Overweight
Price Target: $41
Current: $23.50
Upside: +74.47%
Claritev
Jan 9, 2026
Initiates: Equal-Weight
Price Target: $33
Current: $22.08
Upside: +49.46%
Omada Health
Jan 9, 2026
Initiates: Equal-Weight
Price Target: $17
Current: $11.33
Upside: +50.04%
Omnicell
Jan 5, 2026
Maintains: Overweight
Price Target: $43 → $52
Current: $39.00
Upside: +33.33%
Veeva Systems
Nov 25, 2025
Maintains: Overweight
Price Target: $341 → $333
Current: $186.99
Upside: +78.08%
Health Catalyst
Nov 11, 2025
Maintains: Overweight
Price Target: $6 → $5
Current: $2.05
Upside: +143.90%
American Well
Nov 5, 2025
Maintains: Overweight
Price Target: $12 → $9
Current: $4.41
Upside: +104.08%
May 8, 2025
Maintains: Equal-Weight
Price Target: $10 → $8
Current: $4.85
Upside: +64.95%
Apr 29, 2025
Maintains: Overweight
Price Target: $8 → $7
Current: $2.33
Upside: +200.43%
Feb 26, 2025
Maintains: Overweight
Price Target: $110 → $125
Current: $78.35
Upside: +59.54%